PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY was reported 13 times

These drug classes are most commonly taken by patients reporting PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY:

# Drug Count
0 Corticosteroid [EPC] 6
1 Alkylating Drug [EPC] 3
2 CD30-directed Immunoconjugate [EPC] 2
3 Thalidomide Analog [EPC] 2
4 CD20-directed Cytolytic Antibody [EPC] 1
5 Folate Analog Metabolic Inhibitor [EPC] 1
6 Histone Deacetylase Inhibitor [EPC] 1